Krystal Biotech Inc (NASDAQ:KRYS) COO Suma Krishnan bought 100,000 shares of Krystal Biotech stock in a transaction dated Friday, September 22nd. The stock was acquired at an average cost of $10.00 per share, with a total value of $1,000,000.00. Following the completion of the acquisition, the chief operating officer now owns 1,935,249 shares of the company’s stock, valued at $19,352,490. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

TRADEMARK VIOLATION WARNING: “Krystal Biotech Inc (KRYS) COO Suma Krishnan Purchases 100,000 Shares” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at

About Krystal Biotech

Krystal Biotech, Inc gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases.

Receive News & Ratings for Krystal Biotech Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Krystal Biotech Inc and related companies with's FREE daily email newsletter.